This review identified CHI3L1, CD36, LEPR, RETN, IL-18, RBP-4, and RARRES2 genes as the potential genetic markers of IR and atherosclerosis in T2DM patients with CAD. This evidence concerns the gene LEPR and atherosclerosis.